Madrigal Pharmaceuticals, Inc. (MDGL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 236.16 |
| Open | 237.73 |
| Bid | 244.88 x 100 |
| Ask | 245.69 x 200 |
| Day's range | 235.77 - 245.49 |
| 52-week range | 119.76 - 299.98 |
| Volume | |
| Avg. volume | 508,046 |
| Market cap | 5.232B |
| Beta (5Y monthly) | -0.34 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, Chief Pharmaceutical ...
On May 21, 2024, Robert Waltermire, Senior Vice President and Chief Pharmaceutical Development Officer at Madrigal Pharmaceuticals Inc (NASDAQ:MDGL), sold 1,036 shares of the company.
- Simply Wall St.
3 High Insider Ownership US Stocks With Up To 55% Revenue Growth
Amidst a robust week for U.S. stocks, fueled by significant advancements in AI and cloud computing from major technology firms, the market landscape appears increasingly conducive to exploring growth opportunities. In this context, companies with high insider ownership can be particularly compelling, as they often signal strong confidence from those who know the business best.
- GuruFocus.com
John Paulson's Strategic Moves in Q1 2024 Highlight Madrigal Pharmaceuticals' Prominent Role
Insight into Paulson's Latest 13F Filings and Its Impact on His Investment Portfolio
© 2024 Yahoo. All rights reserved.